AXIM BIOTECHNOLOGIES, INC.·4

Mar 19, 7:39 PM ET

Valencia Catalina 4

4 · AXIM BIOTECHNOLOGIES, INC. · Filed Mar 19, 2024

Insider Transaction Report

Form 4
Period: 2024-03-15
Transactions
  • Award

    Convertible Note

    2024-03-15$156750.00/sh+7,837,500$1,228,528,125,0007,837,500 total
    Exercise: $0.02From: 2024-03-15Exp: 2034-03-01Common Stock (7,837,500 underlying)
Footnotes (1)
  • [F1]Reporting Person acquired a convertible note, face value $156,750. The note is convertible into shares of the Issuer's common stock at a price of $0.02 per share for conversion into a total of 7,837,500 shares..

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT